Szczepionka przeciwko pneumokokom
Charakterystyka, pielęgnacja i opieka

Szczepionki przeciwko pneumokokom, w tym skoniugowane PCV15, PCV20, PCV21 oraz polisacharydowa PPSV23, stanowią kluczowy element profilaktyki zakażeń wywołanych przez Streptococcus pneumoniae. Szczepionki skoniugowane indukują odpowiedź immunologiczną zależną od limfocytów T, zapewniając trwałą odporność śluzówkową i tworzenie komórek pamięci B, natomiast PPSV23 wywołuje krótkotrwałą odpowiedź humoralną bez odporności śluzówkowej, z ochroną utrzymującą się do 5-6 lat. Schematy szczepień różnią się w zależności od wieku i czynników ryzyka: niemowlęta poniżej 5 lat otrzymują 4 dawki PCV15 lub PCV20 (w 2, 4, 6 oraz 12-15 miesiącu życia), dorośli ≥50 lat jedną dawkę PCV20, PCV21 lub PCV15 (z następną dawką PPSV23 po ≥12 miesiącach w przypadku PCV15), a osoby 19-64 lat z ryzykiem – jedną dawkę PCV15 + PPSV23 lub PCV20/PCV21. Szczepienia należy podawać domięśniowo (PCV) lub domięśniowo/podskórnie (PPSV23), z zachowaniem odpowiednich odstępów (min. 4 tygodnie między dawkami u dzieci <12 m.ż., 8 tygodni między PCV15 a PPSV23 u dorosłych 19-64 lat, ≥12 miesięcy u osób ≥65 lat).

Szczepionka przeciwko pneumokokom – wprowadzenie

Szczepionka przeciwko pneumokokom to aktywny środek immunizujący stosowany w celu zapobiegania zakażeniom wywołanym przez bakterie Streptococcus pneumoniae. Działanie szczepionki polega na tym, że powoduje ona wytwarzanie przez organizm własnej ochrony (przeciwciał) przeciwko chorobie12. Szczepionki przeciwko pneumokokom są ważnym elementem profilaktyki zdrowotnej, znacząco zmniejszającym obciążenie chorobami pneumokokowymi zarówno u zaszczepionych osób, jak i w populacji3. Dostępne są dwa rodzaje szczepionek przeciwko pneumokokom: szczepionki skoniugowane (PCV15, PCV20, PCV21) oraz szczepionka polisacharydowa (PPSV23)4.

Rodzaje szczepionek przeciwko pneumokokom

Obecnie dostępne są dwa główne typy szczepionek przeciwko pneumokokom: szczepionki skoniugowane i szczepionka polisacharydowa5. Szczepionki skoniugowane (PCV) zapewniają trwałą ochronę dzięki mechanizmowi działania zależnemu od limfocytów T i wynikającemu z tego tworzeniu komórek pamięci B, które zapewniają odporność śluzówkową. Natomiast szczepionka polisacharydowa (PPSV23) indukuje odpowiedź immunologiczną poprzez uwolnienie immunoglobulin z komórek B, nie powoduje odporności śluzówkowej, a ochrona słabnie po pięciu do sześciu latach6. Obecnie dostępne są następujące szczepionki:

  • Szczepionki skoniugowane: PCV15 (Vaxneuvance), PCV20 (Prevnar 20), PCV21 (CAPVAXIVE)78
  • Szczepionka polisacharydowa: PPSV23 (Pneumovax 23)9

Wskazania do stosowania szczepionki przeciwko pneumokokom

Szczepienie przeciwko pneumokokom jest zalecane dla określonych grup wiekowych oraz osób z czynnikami ryzyka. Główne grupy, którym zaleca się szczepienie, to:1011

Schematy szczepień przeciwko pneumokokom

Schemat dla niemowląt i dzieci

Niemowlęta i małe dzieci zwykle potrzebują 4 dawek szczepionki skoniugowanej przeciwko pneumokokom (PCV15 lub PCV20). Dawki te są rutynowo podawane w wieku 2, 4, 6 miesięcy oraz 12-15 miesięcy1213. Dla dzieci zaszczepionych przed ukończeniem 12. miesiąca życia minimalny odstęp między dawkami wynosi 4 tygodnie. Dawki podawane w wieku 12 miesięcy i starszym należy oddzielić co najmniej 8-tygodniowym odstępem14. Dzieci w wieku od 2 do 18 lat z określonymi schorzeniami medycznymi mogą wymagać dodatkowej dawki szczepionki PPSV2315.

Schemat dla dorosłych

Zalecenia dla dorosłych zależą od wieku, historii szczepień i czynników ryzyka:1617

  • Dorośli w wieku 50 lat i starsi, którzy nie otrzymali wcześniej szczepionki skoniugowanej przeciwko pneumokokom, powinni otrzymać jedną dawkę PCV20, PCV21 lub PCV15 (w przypadku PCV15 należy podać następnie dawkę PPSV23 po co najmniej roku)
  • Dorośli w wieku 19-49 lat z określonymi schorzeniami lub czynnikami ryzyka, którzy nie otrzymali wcześniej szczepionki skoniugowanej, powinni otrzymać jedną dawkę PCV15 (a następnie PPSV23) lub jedną dawkę PCV20 lub PCV21
  • Dorośli, którzy wcześniej otrzymali PPSV23, mogą otrzymać PCV15 lub PCV20 po upływie co najmniej roku
  • Pacjenci, którzy ukończyli serię PCV13 plus PPSV23, nie potrzebują dodatkowego szczepienia z PCV15 lub PCV20

Minimalny akceptowalny odstęp między PCV15 a PPSV23 wynosi 8 tygodni u osób dorosłych w wieku 19-64 lat, a u osób w wieku 65 lat i starszych zaleca się co najmniej roczny odstęp1819.

Technika podawania szczepionki przeciwko pneumokokom

Prawidłowa technika podawania szczepionki jest kluczowa dla zapewnienia jej skuteczności i bezpieczeństwa20:

  • Szczepionki skoniugowane przeciwko pneumokokom (PCV15, PCV20, PCV21) należy podawać domięśniowo21
  • Szczepionkę polisacharydową przeciwko pneumokokom (PPSV23) można podawać domięśniowo lub podskórnie22
  • U niemowląt i małych dzieci preferowanym miejscem podania jest mięsień obszerny boczny uda23
  • U starszych dzieci i dorosłych preferowanym miejscem podania jest mięsień naramienny24
  • Długość igły powinna być odpowiednia do wieku i rozmiaru osoby otrzymującej szczepionkę25

Przed podaniem szczepionki należy wzrokowo sprawdzić, czy nie ma w niej cząstek stałych i/lub przebarwień. Jeśli takie warunki istnieją, NIE należy używać szczepionki26. Ręce należy oczyścić środkiem antyseptycznym na bazie alkoholu lub mydłem i wodą przed przygotowaniem szczepionek do podania27.

Jednoczesne podawanie z innymi szczepionkami

Szczepionkę przeciwko pneumokokom można podawać równocześnie z innymi szczepionkami, ale należy przestrzegać określonych zasad28:

  • Nigdy nie należy podawać szczepionki skoniugowanej przeciwko pneumokokom (PCV15, PCV20 lub PCV21) i PPSV23 podczas tej samej wizyty29
  • U dorosłych można podawać szczepionkę przeciwko pneumokokom (PCV15, PCV20, PCV21 lub PPSV23) podczas tej samej wizyty co szczepionkę przeciwko grypie lub inne zalecane szczepionki30
  • Każdą szczepionkę należy podawać osobną strzykawką i, jeśli to możliwe, w inne miejsce wstrzyknięcia31
  • Małe dzieci mogą być narażone na zwiększone ryzyko drgawek wywołanych gorączką po szczepionce skoniugowanej przeciwko pneumokokom, jeśli jest ona podawana jednocześnie z inaktywowaną szczepionką przeciw grypie32

Przeciwwskazania i środki ostrożności

Przed podaniem szczepionki przeciwko pneumokokom należy wziąć pod uwagę następujące przeciwwskazania i środki ostrożności3334:

  • Przeciwwskazania:
    • Ciężka reakcja alergiczna (anafilaksja) po wcześniejszej dawce szczepionki lub na jakikolwiek składnik szczepionki35
  • Środki ostrożności:
    • Osoby z wysoką gorączką lub zbyt złym samopoczuciem, aby wykonywać normalne czynności, powinny poczekać z przyjęciem szczepionki do czasu poprawy stanu zdrowia36
    • U osób z obniżoną odpornością, w tym osób otrzymujących terapię immunosupresyjną, może wystąpić zmniejszona odpowiedź immunologiczna na szczepionkę37
    • Szczepionka może nie być skuteczna w zapobieganiu zapaleniu opon mózgowych u pacjentów z przewlekłym wyciekiem płynu mózgowo-rdzeniowego (CSF) wynikającym z wrodzonych zmian, złamań czaszki lub zabiegów neurochirurgicznych38

Szczepionki przeciwko pneumokokom nie są ogólnie zalecane dla kobiet w ciąży39. Kobiety w ciąży powinny skonsultować się ze swoim lekarzem ginekologiem-położnikiem przed zaszczepieniem40.

Działania niepożądane po szczepieniu

Szczepionki przeciwko pneumokokom są ogólnie bezpieczne, ale jak każdy lek, mogą powodować działania niepożądane. Większość działań niepożądanych jest łagodna i zazwyczaj ustępuje w ciągu kilku dni41.

Częste działania niepożądane

  • Reakcje w miejscu wstrzyknięcia:
    • Zaczerwienienie, obrzęk, ból lub tkliwość w miejscu podania4243
    • Czasami guzek w miejscu wstrzyknięcia (może utrzymywać się przez wiele tygodni – nie wymaga leczenia)44
  • Reakcje ogólnoustrojowe:
    • Łagodna gorączka45
    • Uczucie zmęczenia46
    • Utrata apetytu47
    • Drażliwość (szczególnie u dzieci)48
    • Ból głowy49
    • Bóle mięśni lub stawów50
    • Dreszcze51

Rzadkie działania niepożądane

Szczepionka przeciwko pneumokokom może w rzadkich przypadkach wywołać poważną reakcję alergiczną zwaną anafilaksją52. Anafilaksja może zagrażać życiu i wymaga natychmiastowej pomocy medycznej. Reakcja alergiczna może wystąpić po opuszczeniu kliniki przez zaszczepioną osobę53. Objawy ciężkiej reakcji alergicznej mogą obejmować54:

  • Pokrzywkę
  • Obrzęk twarzy i gardła
  • Trudności w oddychaniu
  • Szybkie bicie serca
  • Zawroty głowy lub osłabienie

Opieka i postępowanie po szczepieniu

Po szczepieniu przeciwko pneumokokom ważne jest monitorowanie pacjenta i odpowiednie postępowanie w przypadku wystąpienia działań niepożądanych55:

  • W przypadku bólu w miejscu wstrzyknięcia można zastosować:
    • Ciepły, wilgotny kompres lub podkładkę grzewczą na miejsce wstrzyknięcia56
    • Leki przeciwbólowe dostępne bez recepty, takie jak paracetamol (Tylenol), ibuprofen (Advil, Motrin) lub naproksen (Aleve)57
  • Łagodna gorączka i ból powinny ustąpić w ciągu 3 dni lub krócej58
  • Należy uważnie obserwować zmiany w stanie zdrowia i skontaktować się z lekarzem w przypadku wystąpienia jakichkolwiek problemów59

W przypadku zauważenia objawów ciężkiej reakcji alergicznej (pokrzywka, obrzęk twarzy i gardła, trudności w oddychaniu, szybkie bicie serca, zawroty głowy lub osłabienie) należy natychmiast zadzwonić pod numer alarmowy i przetransportować osobę do najbliższego szpitala60.

Opieka pielęgniarska w placówkach długoterminowej opieki

Zapobieganie chorobom pneumokokowym jest priorytetem narodowym w zakresie zdrowia, szczególnie u osób starszych, a zwłaszcza w placówkach opieki długoterminowej (LTC)61. Przepisy dotyczące licencjonowania domów opieki wymagają, aby placówki oceniały status szczepień przeciwko pneumokokom każdego mieszkańca, zapewniały edukację dotyczącą szczepień przeciwko pneumokokom i podawały odpowiednią szczepionkę przeciwko pneumokokom, gdy jest to wskazane62.

Zalecenia dla placówek opieki długoterminowej

Departament Zdrowia zaleca, aby placówki opieki długoterminowej (LTC) podjęły następujące kroki63:

  • Zrewidowanie obecnych polityk immunizacyjnych i/lub przyjęcie stałych zleceń, aby zapewnić, że wszyscy mieszkańcy są badani i oferowana jest im odpowiednia szczepionka przeciwko pneumokokom
  • W przypadku mieszkańców przebywających na długoterminowym pobycie, placówki powinny ponownie ocenić potrzebę kolejnych dawek szczepionki przeciwko pneumokokom zgodnie z zaleceniami ACIP
  • Zapewnienie, aby wszyscy pracownicy byli edukowani na temat szczepionek przeciwko pneumokokom oraz wieku i schorzeń, w przypadku których zalecane jest szczepienie, podczas corocznej oceny zdrowia pracowników
  • Placówki LTC powinny oferować odpowiednią szczepionkę przeciwko pneumokokom pracownikom, gdy jest to wskazane

Ponadto, szczepienia nie powinny być opóźniane z powodu braku pisemnej dokumentacji szczepień. Jeśli dokumentacja szczepień nie jest dostępna, dopuszczalne jest poleganie na ustnej historii szczepień pacjenta w celu ustalenia, czy i która szczepionka przeciwko pneumokokom jest wskazana64.

Narzędzia dla placówek opieki długoterminowej

W celu wsparcia placówek opieki długoterminowej opracowano szereg narzędzi edukacyjnych i wdrożeniowych, które mają pomóc świadczeniodawcom przy ocenie mieszkańców pod kątem potrzeb związanych ze szczepieniami przeciwko pneumokokom65. Narzędzia te obejmują66:

  • Dokument zawierający wytyczne dotyczące szczepień przeciwko pneumokokom, sformatowany przy użyciu podejścia opartego na często zadawanych pytaniach. Wytyczne odpowiadają na typowe pytania dotyczące szczepień przeciwko pneumokokom i przedstawiają szereg typowych scenariuszy klinicznych mających na celu pomoc świadczeniodawcom w wyborze odpowiednich strategii szczepień
  • Notatka dotycząca oceny szczepień przeciwko pneumokokom mieszkańców, która pomaga personelowi domów opieki w przeprowadzeniu wymaganej oceny szczepień przeciwko pneumokokom mieszkańców poprzez wykorzystanie szablonu notatki

Edukacja pacjentów i rodzin

Edukacja pacjentów i ich rodzin jest kluczowym elementem skutecznego programu szczepień przeciwko pneumokokom67. Badania pokazują, że gdy pracownik służby zdrowia zdecydowanie zaleca szczepienie pacjentowi, wskaźniki immunizacji wzrastają68.

Kluczowe informacje dla pacjentów

Podczas edukowania pacjentów i ich rodzin na temat szczepionki przeciwko pneumokokom, należy przekazać następujące informacje69:

  • Korzyści ze szczepionki przeciwko pneumokokom:
    • Szczepionka przeciwko pneumokokom zapobiega chorobom pneumokokowym, które mogą powodować poważne zakażenia płuc (zapalenie płuc), krwi (bakteriemia) i opon mózgowo-rdzeniowych (zapalenie opon mózgowych)70
    • Szczepionki są bardzo skuteczne w zapobieganiu ciężkim przypadkom choroby, które mogłyby wymagać hospitalizacji71
    • Szczepienie jest szczególnie ważne dla osób z grup wysokiego ryzyka72
  • Jakich działań niepożądanych można się spodziewać:
    • Możliwe łagodne działania niepożądane, takie jak ból, zaczerwienienie lub obrzęk w miejscu wstrzyknięcia, łagodna gorączka, zmęczenie i utrata apetytu73
    • Poważne działania niepożądane są bardzo rzadkie74
  • Kiedy należy skontaktować się z lekarzem:
    • Jeśli pojawią się oznaki ciężkiej reakcji alergicznej75
    • Jeśli działania niepożądane nie ustępują po kilku dniach lub się nasilają76

Podejście SHARE

Pracownicy służby zdrowia mogą wdrożyć podejście SHARE, aby zwiększyć zaufanie pacjenta do szczepionki77. Podejście to obejmuje:

  • S – Sharing (Dzielenie się) informacjami o tym, dlaczego szczepionka jest odpowiednia dla pacjenta w oparciu o jego wiek i stan zdrowia
  • H – Highlighting (Podkreślanie) pozytywnych doświadczeń ze szczepionką
  • A – Addressing (Odnoszenie się) do obaw pacjenta w empatyczny sposób
  • R – Reminding (Przypominanie) pacjentom, że szczepionki chronią ich i ich bliskich
  • E – Explaining (Wyjaśnianie) potencjalnych skutków ubocznych

Rola zespołu interdyscyplinarnego

Skuteczne wdrożenie programu szczepień przeciwko pneumokokom wymaga współpracy interdyscyplinarnego zespołu opieki zdrowotnej78. Wszyscy członkowie zespołu opieki zdrowotnej, w tym lekarze, personel pielęgniarski i farmaceuci, powinni edukować pacjentów na temat korzyści płynących ze szczepionki przeciwko pneumokokom, odpowiadać na pytania pacjentów, łagodzić wszelkie obawy, które mogą mieć odnośnie szczepionki, oraz dostarczać informacji dla pacjenta w mało prawdopodobnym przypadku wystąpienia niepożądanej reakcji79.

Rola zespołu pielęgniarskiego

Pielęgniarki odgrywają kluczową rolę w programie szczepień przeciwko pneumokokom80:

  • Ocena stanu szczepień pacjentów i identyfikacja tych, którzy kwalifikują się do szczepienia
  • Informowanie pacjentów o ryzyku związanym z chorobą pneumokokową, korzyściach ze szczepionki oraz ryzykach i przeciwwskazaniach dla szczepionki
  • Właściwe przechowywanie i przygotowanie szczepionek
  • Prawidłowe podawanie szczepionek zgodnie z zasadą „7 praw”: właściwy pacjent, właściwy czas, właściwa szczepionka (i rozcieńczalnik), właściwa dawka, właściwa droga, igła i technika, właściwe miejsce wstrzyknięcia oraz właściwa dokumentacja
  • Monitorowanie pacjentów pod kątem niepożądanych reakcji po szczepieniu
  • Odpowiednie dokumentowanie szczepień

Budowanie społeczności akceptacji szczepionek

Pracownicy służby zdrowia mogą budować społeczność akceptacji szczepionek w ramach praktyki poprzez dyskusje, edukację i szkolenie całego personelu w praktyce na temat szczepień przeciwko pneumokokom, aby zainicjować podejście zespołowe81. Wdrożenie metody Plan-Do-Study-Act (PDSA) może pomóc w tworzeniu interwencji opartych na dowodach, które tworzą trwałe zmiany82.

Skuteczność szczepionki przeciwko pneumokokom

Szczepionki przeciwko pneumokokom są bardzo skuteczne w zapobieganiu chorobom pneumokokowym83. Są one szczególnie skuteczne w zapobieganiu ciężkim przypadkom choroby, które mogłyby prowadzić do hospitalizacji lub śmierci84.

U dzieci, 3 dawki 13-walentnej skoniugowanej szczepionki przeciwko pneumokokom (PCV13) są w około 90% skuteczne w zapobieganiu inwazyjnej chorobie pneumokokowej wywołanej przez serotypy zawarte w szczepionce85. U dorosłych, metaanaliza 18 badań z udziałem ponad 700 000 uczestników wykazała, że 23-walentna polisacharydowa szczepionka przeciwko pneumokokom (PPV23) zapewniała ochronę przed niektórymi zdarzeniami sercowo-naczyniowymi, szczególnie zawałem serca u osób zaszczepionych, zwłaszcza u osób w wieku 65 lat i starszych86.

Obiecujące badania sugerują również, że szczepionka przeciwko pneumokokom może być związana ze zmniejszonym ryzykiem rozwoju choroby Alzheimera87. „Szczepienia przeciwko zapaleniu płuc przed 75 rokiem życia mogą zmniejszyć ryzyko choroby Alzheimera w późniejszym życiu, w zależności od [składu genetycznego],” powiedziała w komunikacie prasowym dr Svetlana Ukraintseva, autorka badania88.

Podsumowanie zaleceń

Grupa wiekowa Zalecenia dotyczące szczepień Dodatkowe informacje
Niemowlęta i dzieci w wieku <5 lat 4 dawki PCV15 lub PCV20 w wieku 2, 4, 6 i 12-15 miesięcy Dla dzieci zaszczepionych przed 12. miesiącem życia minimalny odstęp między dawkami wynosi 4 tygodnie
Dzieci w wieku 5-18 lat z określonymi schorzeniami PCV15 lub PCV20, może być wskazane PPSV23 Schemat zależny od wcześniejszej historii szczepień
Dorośli w wieku 19-49 lat z czynnikami ryzyka Jednorazowa dawka PCV20 lub PCV21, lub PCV15 + PPSV23 W przypadku PCV15 następna dawka PPSV23 powinna być podana po co najmniej 8 tygodniach
Dorośli w wieku 50 lat i starsi Jednorazowa dawka PCV20, PCV21 lub PCV15 + PPSV23 W przypadku PCV15 następna dawka PPSV23 powinna być podana po co najmniej roku
Dorośli z wcześniejszą dawką PPSV23 Można podać PCV20 lub PCV15 co najmniej 1 rok po PPSV23 Pacjenci, którzy ukończyli serię PCV13 + PPSV23, nie potrzebują dodatkowych szczepień

W każdym przypadku, pacjent powinien skonsultować się z lekarzem w celu ustalenia optymalnego schematu szczepień w oparciu o swój wiek, historię szczepień i czynniki ryzyka8990.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Pneumococcal vaccine polyvalent Advanced Patient Information – Drugs.com
    https://www.drugs.com/cons/pneumococcal-vaccine-polyvalent.html
    Pneumococcal polyvalent vaccine is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to produce its own protection (antibodies) against the disease. […] Immunization (vaccination) against pneumococcal disease is recommended for all adults and children 2 years of age and older, especially: Older adults, especially those 65 years of age and older. […] This vaccine is to be administered only by or under the supervision of your doctor or other health care professional. […] A nurse or other trained health professional will give you or your child this vaccine. This vaccine is given as a shot into one of the muscles or under the skin, usually in the thigh or upper arm. […] If you have more than one doctor, be sure they all know that you have received pneumococcal vaccine polyvalent 23 so that they can put the information into your medical records.
  • #2 Pneumococcal vaccine polyvalent (intramuscular route, subcutaneous route) – Mayo Clinic
    https://www.mayoclinic.org/drugs-supplements/pneumococcal-vaccine-polyvalent-intramuscular-route-subcutaneous-route/description/drg-20065538
    Pneumococcal polyvalent vaccine is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to produce its own protection (antibodies) against the disease. […] Immunization (vaccination) against pneumococcal disease is recommended for all adults and children 2 years of age and older, especially: Older adults, especially those 65 years of age and older. […] This vaccine is to be administered only by or under the supervision of your doctor or other health care professional. […] A nurse or other trained health professional will give you or your child this vaccine. This vaccine is given as a shot into one of the muscles or under the skin, usually in the thigh or upper arm. […] If you have more than one doctor, be sure they all know that you have received pneumococcal vaccine polyvalent 23 so that they can put the information into your medical records.
  • #3 Pneumococcal vaccination in adults – UpToDate
    https://www.uptodate.com/contents/pneumococcal-vaccination-in-adults
    Pneumococcal vaccination is an important preventive health care measure that substantially reduces the burden of pneumococcal disease in vaccinated individuals and in the population. Pneumococcal vaccination is indicated for adults with risk factors for pneumococcal disease or for severe adverse outcomes should disease occur. Pneumococcal vaccination is also a routine part of infant and childhood immunization schedules worldwide. […] This topic will review types of pneumococcal vaccines, indications and approach to vaccine selection, safety of vaccination, and rationale for vaccination. […] Two types of pneumococcal vaccines are available for clinical use: pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV). […] PPSV is composed of partially purified pneumococcal capsular polysaccharides. The only available formulation contains 23 pneumococcal polysaccharides (PPSV23; Pneumovax or Pnu-Immune) from the 23 serotypes that were the most common cause of pneumococcal disease in adults in the 1980s. […] However, it remains uncertain whether a conjugate vaccine is truly more effective than PPSV in adults.
  • #4 Pneumococcal Disease and Vaccine | Washington State Department of Health
    https://doh.wa.gov/you-and-your-family/immunization/diseases-and-vaccines/pneumococcal-vaccine
    Getting vaccinated is the best way to prevent pneumococcal disease. There are two approved pneumococcal vaccine types in the United States. Additionally, getting the flu vaccine every year reduces the chance of getting pneumococcal disease. […] The United States uses two different types of pneumococcal vaccines to help protect against pneumococcal disease: Pneumococcal conjugate vaccines (PCV15, PCV20, or PCV21) and Pneumococcal polysaccharide vaccine (PPSV23). […] For children: Children younger than 5 years old should get PCV15 or PCV20. Children 5 through 18 years old with certain medical conditions. […] For adults: Adults 50 years and older should receive PCV15, PCV20, or PCV21. Adults 19 through 49 years of age and have certain medical conditions should receive PCV15, PCV20, or PCV21. Adults receiving PCV15 should receive a follow-up dose of PPSV23.
  • #5 Pneumococcal vaccine – Wikipedia
    https://en.wikipedia.org/wiki/Pneumococcal_vaccine
    Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines. They are given by injection either into a muscle or just under the skin. […] The World Health Organization (WHO) recommends the use of the conjugate vaccine in the routine immunizations given to children. This includes those with HIV/AIDS. The recommended three or four doses are between 71 and 93% effective at preventing severe pneumococcal disease. […] These vaccines are generally safe. With the conjugate vaccine about 10% of babies develop redness at the site of injection, fever, or change in sleep. Severe allergies are very rare. […] The national vaccination program started vaccinating newborns in 2004 with the 7-valent pneumococcal conjugate vaccine (PCV 7). This was changed into the 13-valent conjugate (PCV 13) in 2011. The switch to the 10-valent conjugate (PCV 10) was made in July 2015 in Flanders and May 2016 in Wallonia.
  • #6 Simplifying Pneumococcal Immunizations for Adults | AAFP
    https://www.aafp.org/pubs/afp/issues/2022/0600/p580.html
    All patients 65 years or older should be given either PCV20 once or PCV15 followed by PPSV23 at least one year later. […] The ACIP has removed distinctions among people with chronic medical conditions, immunocompromising conditions, or underlying conditions (e.g., cochlear implants, cerebrospinal fluid leaks). […] Adults who have received PPSV23 alone may be given PCV20 or PCV15 after at least one year. […] Patients who have completed the PCV13 plus PPSV23 series do not need additional vaccination with PCV15 or PCV20. […] PCV15 and PCV20 are expected to be approved for use in children within the next year or so. […] These new straightforward guidelines will hopefully help increase suboptimal pneumococcal vaccination rates, which remain around 70% for patients 65 years or older and less than 25% for individuals with high-risk conditions.
  • #7 Pneumococcal Vaccine | L.A. Care Health Plan
    https://www.lacare.org/members/getting-care/pharmacy-services/vaccines/pneumococcal
    Pneumococcal vaccines are very good at preventing severe cases of disease that could send you to the hospital. […] Getting the vaccine can protect you, and it is especially important if you are in a higher risk group. […] All children younger than 2 years and all adults 65 years and older should get vaccinated against pneumococcal disease. […] People between the ages of 2 to 64 with certain medical conditions (such as high blood sugar or anyone with heart, liver, kidney, and lung diseases) and people who smoke cigarettes should also be vaccinated. […] There are currently four shots that protect against pneumococcal disease: Vaxneuvance (PCV15), Prevnar 20 (PCV20), Pneumovax (PPSV23), and Prevnar 13 (PCV13). One or two doses are recommended, depending on your age and health. […] You can get your pneumococcal shots at your local pharmacy or your doctor’s office.
  • #8
    https://www.healio.com/news/primary-care/20230406/what-physicians-need-to-know-to-ensure-simpler-pneumococcal-vaccine-management
    To avoid uncertainty, an expert recommends physicians understand each vaccines serotypes and which ones are being phased out. […] The 20-valent pneumococcal conjugate vaccine may be preferable due to convenience. […] Currently, there are four pneumococcal vaccinations licensed for use, which include: 20-valent pneumococcal conjugate vaccine (PCV20; Pfizer); 15-valent pneumococcal conjugate vaccine (PCV15; Merck); 13-valent pneumococcal conjugate vaccine (PCV13; Wyeth Pharmaceuticals); and 23-valent pneumococcal polysaccharide vaccine (PPSV23; Merck). […] The indications and schedules for the vaccines vary. All four vaccines are approved for adults. […] Ultimately, the advent of those newer vaccines will raise a lot of questions in physicians minds and lead to confusion, he said. […] The CDC recommends one dose of the PCV13 vaccine for children at four different ages: 2 months, 4 months, 6 months and 12 to 15 months.
  • #9 Pneumococcal vaccination in adults – UpToDate
    https://www.uptodate.com/contents/pneumococcal-vaccination-in-adults
    Pneumococcal vaccination is an important preventive health care measure that substantially reduces the burden of pneumococcal disease in vaccinated individuals and in the population. Pneumococcal vaccination is indicated for adults with risk factors for pneumococcal disease or for severe adverse outcomes should disease occur. Pneumococcal vaccination is also a routine part of infant and childhood immunization schedules worldwide. […] This topic will review types of pneumococcal vaccines, indications and approach to vaccine selection, safety of vaccination, and rationale for vaccination. […] Two types of pneumococcal vaccines are available for clinical use: pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV). […] PPSV is composed of partially purified pneumococcal capsular polysaccharides. The only available formulation contains 23 pneumococcal polysaccharides (PPSV23; Pneumovax or Pnu-Immune) from the 23 serotypes that were the most common cause of pneumococcal disease in adults in the 1980s. […] However, it remains uncertain whether a conjugate vaccine is truly more effective than PPSV in adults.
  • #10 Why It’s Time to Consider the Pneumococcal Vaccine | HealthFocus SA | University Health
    https://universityhealth.com/blog/why-its-time-to-consider-the-pneumococcal-vaccine
    Most of us are familiar with the flu shot or the COVID-19 vaccine, but what about the pneumococcal vaccine? This vaccine often flies under the radar, and yet it protects against a potentially serious and even life-threatening illness: pneumococcal disease. […] The Centers for Disease Control and Prevention (CDC) recommends the following groups get the pneumococcal vaccine: Children under 5 years old, Adults aged 50 and older, Anyone aged 19-49 with the underlying chronic conditions listed below: Diabetes, Heart disease, Asthma, Chronic obstructive pulmonary disease (COPD), Anyone with a weakened immune system. […] You can benefit from the vaccine even if you are a healthy adult over 50. Our immune systems naturally weaken as we age, making it harder to fight off infections like pneumococcal pneumonia.
  • #11 Pneumococcal disease | The Australian Immunisation Handbook
    https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease
    The optimal pneumococcal vaccination program for Australia is currently under review. At present Prevenar 13 (13vPCV) and Pneumovax 23 (23vPPV) are the pneumococcal vaccines funded under the National Immunisation Program (NIP) for eligible individuals. […] Pneumococcal vaccine is recommended for: infants and children aged <5 years, non-Indigenous adults aged ≥70 years, Aboriginal and Torres Strait Islander adults aged ≥50 years, children, adolescents and adults with risk conditions for pneumococcal disease. [...] There are two types of pneumococcal vaccines registered in Australia: Pneumococcal conjugate vaccines: Prevenar 13 - 13vPCV (13-valent pneumococcal conjugate vaccine), Vaxneuvance - 15vPCV (15-valent pneumococcal conjugate vaccine), and Prevenar 20 - 20vPCV (20-valent pneumococcal conjugate vaccine)
  • #12 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #13 Your Child’s Vaccines: Pneumococcal Vaccines (PCV, PPSV) (for Parents) | Nemours KidsHealth
    https://kidshealth.org/en/parents/pneumococcal-vaccine.html
    The pneumococcal conjugate vaccines (PCV15, PCV20) and the pneumococcal polysaccharide vaccine (PPSV23) protect against pneumococcal infections. […] The pneumococcal vaccines protect against the different types of pneumococcal bacteria that cause the most common and serious pneumococcal infections in kids and adults. […] Infants get PCV vaccines as a series of four shots: the first at 2 months of age, then at 4 months, 6 months, and 12-15 months. […] Older kids and teens might need one or more shots of a PCV or PPSV23 vaccine if they missed getting the recommended shots when they were younger, or if they have certain chronic health conditions or a condition that weakens the immune system. […] Children younger than 2 years old, adults over 65, and people with some medical conditions are at high risk for serious pneumococcal infections.
  • #14 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    CDC recommends a fourth (booster) dose at 12 through 15 months of age. […] For children vaccinated when they are younger than 12 months of age, the minimum interval between doses is 4 weeks. […] Separate doses given at 12 months of age and older by at least 8 weeks. […] The number and timing of doses for older children and adults depends on the medical indication, prior pneumococcal vaccination, and age. […] There are no data on the stability of vaccines stored in syringes filled by health care professionals. Therefore, CDC does not recommend predrawing vaccine doses. […] Never administer a pneumococcal conjugate vaccine (PCV15, PCV20, or PCV21) and PPSV23 during the same visit. […] If someone is indicated to receive PCV15 and PPSV23, administer PCV15 first followed by PPSV23. […] For children (2 through 18 years old), the interval between PCV15 and PPSV23 should be at least 8 weeks.
  • #15
    https://www.advocatehealth.com/health-services/primary-care/preventive-care/vaccinations/pneumococcal
    Vaccines are an important part of preventing severe illnesses and their complications. […] But vaccinations such as the pneumococcal vaccine could prevent many of these deaths. […] Our preventive care team offers the pneumococcal vaccine and other routine vaccinations in many convenient locations throughout the Chicago metro area. […] Experts recommend that infants, older adults and some high-risk people get the pneumococcal vaccine. […] Your age and health history affect when the pneumococcal vaccine is recommended. […] Infants should get four doses of either PCV13 or PCV15 at: Less than 2 months old, 4 months old, 6 months old, 12 to 15 months old. […] Your child’s health care provider may recommend getting PPSV23 between ages 2 and 18 if they have other medical conditions that increase their risk.
  • #16 Simplifying Pneumococcal Immunizations for Adults | AAFP
    https://www.aafp.org/pubs/afp/issues/2022/0600/p580.html
    All patients 65 years or older should be given either PCV20 once or PCV15 followed by PPSV23 at least one year later. […] The ACIP has removed distinctions among people with chronic medical conditions, immunocompromising conditions, or underlying conditions (e.g., cochlear implants, cerebrospinal fluid leaks). […] Adults who have received PPSV23 alone may be given PCV20 or PCV15 after at least one year. […] Patients who have completed the PCV13 plus PPSV23 series do not need additional vaccination with PCV15 or PCV20. […] PCV15 and PCV20 are expected to be approved for use in children within the next year or so. […] These new straightforward guidelines will hopefully help increase suboptimal pneumococcal vaccination rates, which remain around 70% for patients 65 years or older and less than 25% for individuals with high-risk conditions.
  • #17
    https://www.healio.com/news/primary-care/20230406/what-physicians-need-to-know-to-ensure-simpler-pneumococcal-vaccine-management
    For children and adolescents aged 5 to 18 years with certain medical conditions, a single dose of PCV13 is recommended if they have not received any doses already. […] When determining which PCV to use in children, Schaffner explained one significant simplifying factor is that PCV13 is being phased out. […] It will likely be replaced by PCV20, he said. […] Schaffner added that PCV13 no longer has a role in adult immunization, unless PCV15 and PCV20 are unavailable. […] For adult patients who have not received any prior vaccinations, the CDC recommends a single dose of PCV15, followed by a dose of PPSV23, for those aged: 19 to 64 years who have certain medical conditions or risk factors; and 65 years and older. […] For adult patients who have not received prior vaccinations, a single dose of PCV20 is recommended for those aged: 19 to 64 years who have certain medical conditions or risk factors; and 65 years and older.
  • #18 DAL NH 16-01: Pneumococcal Vaccine
    https://www.health.state.ny.us/professionals/nursing_home_administrator/dal_nh_16-01_pneumococcal_vaccine.htm
    For adults 19-64 years of age, the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The two vaccines must not be co-administered, and the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The Department recommends LTCFs take the following steps immediately: Revise their current immunization policies and/or adopt the attached non-patient specific standing orders to ensure that all residents are screened and offered the appropriate pneumococcal vaccine. […] Ensure that all employees are educated about the pneumococcal vaccines and the ages and medical conditions for which vaccination is recommended, at their annual employee health assessment. […] Furthermore, vaccination should not be delayed due to a lack of a written immunization record. If immunization records are not available, it is acceptable to rely on the patient’s verbal immunization history to determine whether and which pneumococcal vaccine is indicated.
  • #19 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    For adults, the recommended interval is at least 1 year. […] In adults, you can administer a pneumococcal vaccine (PCV15, PCV20, PCV21, or PPSV23) during the same visit with influenza vaccination or other recommended vaccines. […] Administer each vaccine with a separate syringe and, if feasible, at a different injection site. […] Routine administration of a pneumococcal vaccine with other age-appropriate doses of vaccines at the same visit is recommended for adults who have no specific contraindications to vaccination at the time of the health care visit.
  • #20 American Nurse Today November 2016: Which Pneumococcal Vaccine And When? A Guide For Nurses
    https://americannursetoday.mydigitalpublication.com/articles/which-pneumococcal-vaccine-and-when-a-guide-for-nurses
    Learn how PPSV23 and PCV13 differ and when to give each one. […] Knowing which one to give and when to give it can be confusing. Whats more, giving the wrong one at the wrong time can leave your patient unprotected against pneumococcal disease. This article explains when and how to administer these vaccines to adults and presents recommendations from the Advisory Committee on Immunization Practices (ACIP. […] ACIP recommends giving these vaccines at certain intervals relative to each other. Administering them too close together makes them less effective, leaving patients without adequate protection against pneumonia. […] As with any vaccine, keep the 7 rights in mind when administering PPSV23 or PCV13right patient; right time; right vaccine (and diluent); right dosage; right route, needle, and technique; right injection site; and right documentation.
  • #21 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #22 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #23 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #24 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #25 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #26 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    Do not use any pneumococcal vaccine beyond the expiration date printed on the label. […] Prior to administration, visually inspect the vaccine for particulate matter and/or discoloration. If these conditions exist, do NOT use. […] Administer pneumococcal polysaccharide vaccine (PPSV23) intramuscularly or subcutaneously. […] Administer pneumococcal conjugate vaccines (PCV15, PCV20) intramuscularly. […] For infants and young children, use the vastus lateralis muscle in the anterolateral thigh. […] For older children and adults, use the deltoid muscle. […] Administer pneumococcal conjugate vaccine (PCV21) to adults intramuscularly using the deltoid muscle. […] Use a needle length appropriate for the age and size of the person receiving the vaccine. […] The primary series of PCV15 or PCV20 consists of 3 doses routinely given at 2, 4, and 6 months of age.
  • #27 Pneumococcal Vaccine – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK507794/
    The advent of pneumococcal vaccines has proven to be a significant advancement in treating and preventing a widespread and sometimes deadly disease process. […] This activity describes the mode of action of pneumococcal vaccines, including methods of administration, formulations, adverse event profiles, eligible patient populations, and monitoring, and highlights the role of the interprofessional team in the management of these patients. […] Vaccines should be discarded if there is the presence of particulate matter and discoloration in the solution. […] Hands should be cleansed with an alcohol-based antiseptic hand rub or with soap and water before preparing vaccines for administration. […] The pneumococcal vaccine is safe and effective and can help reduce the risk of infection with certain types of pneumonia, sepsis, and meningitis.
  • #28 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    For adults, the recommended interval is at least 1 year. […] In adults, you can administer a pneumococcal vaccine (PCV15, PCV20, PCV21, or PPSV23) during the same visit with influenza vaccination or other recommended vaccines. […] Administer each vaccine with a separate syringe and, if feasible, at a different injection site. […] Routine administration of a pneumococcal vaccine with other age-appropriate doses of vaccines at the same visit is recommended for adults who have no specific contraindications to vaccination at the time of the health care visit.
  • #29 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    CDC recommends a fourth (booster) dose at 12 through 15 months of age. […] For children vaccinated when they are younger than 12 months of age, the minimum interval between doses is 4 weeks. […] Separate doses given at 12 months of age and older by at least 8 weeks. […] The number and timing of doses for older children and adults depends on the medical indication, prior pneumococcal vaccination, and age. […] There are no data on the stability of vaccines stored in syringes filled by health care professionals. Therefore, CDC does not recommend predrawing vaccine doses. […] Never administer a pneumococcal conjugate vaccine (PCV15, PCV20, or PCV21) and PPSV23 during the same visit. […] If someone is indicated to receive PCV15 and PPSV23, administer PCV15 first followed by PPSV23. […] For children (2 through 18 years old), the interval between PCV15 and PPSV23 should be at least 8 weeks.
  • #30 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    For adults, the recommended interval is at least 1 year. […] In adults, you can administer a pneumococcal vaccine (PCV15, PCV20, PCV21, or PPSV23) during the same visit with influenza vaccination or other recommended vaccines. […] Administer each vaccine with a separate syringe and, if feasible, at a different injection site. […] Routine administration of a pneumococcal vaccine with other age-appropriate doses of vaccines at the same visit is recommended for adults who have no specific contraindications to vaccination at the time of the health care visit.
  • #31 Administering Pneumococcal Vaccine: For Providers | CDC
    https://www.cdc.gov/vaccines/vpd/pneumo/hcp/administering-vaccine.html
    For adults, the recommended interval is at least 1 year. […] In adults, you can administer a pneumococcal vaccine (PCV15, PCV20, PCV21, or PPSV23) during the same visit with influenza vaccination or other recommended vaccines. […] Administer each vaccine with a separate syringe and, if feasible, at a different injection site. […] Routine administration of a pneumococcal vaccine with other age-appropriate doses of vaccines at the same visit is recommended for adults who have no specific contraindications to vaccination at the time of the health care visit.
  • #32 Pneumococcal Conjugate Vaccine: What You Need to Know | Saint Luke’s Health System
    https://www.saintlukeskc.org/health-library/pneumococcal-conjugate-vaccine-what-you-need-know
    Adults 65 years or older who have not previously received pneumococcal conjugate vaccine should receive pneumococcal conjugate vaccine. […] Your health care provider can give you more information. […] Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, muscle aches, joint pain, and chills can happen after pneumococcal conjugate vaccination. […] Young children may be at increased risk for seizures caused by fever after a pneumococcal conjugate vaccine if it is administered at the same time as inactivated influenza vaccine. […] As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death. […] An allergic reaction could occur after the vaccinated person leaves the clinic. […] Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS).
  • #33 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Pneumococcal conjugate vaccine (PCV13, PCV15, PCV20, and PCV21) can prevent pneumococcal disease. […] Pneumococcal conjugate vaccine helps protect against bacteria that cause pneumococcal disease. […] Infants and young children usually need 4 doses of pneumococcal conjugate vaccine (PCV15 or PCV20), at ages 2 months, 4 months, 6 months, and 12–15 months. […] Adults 19–50 years old with certain medical conditions or other risk factors who have not already received a pneumococcal conjugate vaccine should receive either: a single dose of PCV15 followed by a dose of pneumococcal polysaccharide vaccine (PPSV23), or a single dose of PCV20 or a single dose of PCV21. […] Tell your vaccination provider if the person getting the vaccine has had an allergic reaction after a previous dose of PCV13, PCV15, PCV20, PCV21 or to an earlier pneumococcal conjugate vaccine known as PCV7, or to any vaccine containing diphtheria toxoid (for example, DTaP), or has any severe, life-threatening allergies.
  • #34 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    The pneumococcal vaccine helps protect against serious illnesses like pneumonia and meningitis. It’s recommended for people at higher risk of these illnesses, such as babies and adults aged 65 and over. […] The pneumococcal vaccine is recommended for babies, older people, and people at higher risk of getting seriously ill from pneumococcal infections. […] Contact your GP surgery if you or your child have missed a pneumococcal vaccination. […] Most people can have the pneumococcal vaccine if they need it, including if you’re pregnant or breastfeeding. […] You only cannot have the vaccine if you’ve had a serious allergic reaction (anaphylaxis) to a previous dose of the vaccine or an ingredient in the vaccine. […] If you or your child have a high temperature or feel too unwell to do your normal activities, wait until you’re feeling better before having the vaccine.
  • #35 Pneumococcal vaccine | Australian Government Department of Health and Aged Care
    https://www.health.gov.au/topics/immunisation/vaccines/pneumococcal-immunisation-service
    Pneumococcal vaccines should not be given to people who have had: anaphylaxis after a previous dose of any pneumococcal vaccine, anaphylaxis after any component of a pneumococcal vaccine. […] Pneumococcal vaccines are not generally recommended for pregnant women. […] Pneumococcal vaccines only come as a single vaccine, not as a combination vaccine. Different vaccines protect against different types of pneumococcal disease. It is given as a needle, usually in the upper arm. […] Common side effects of pneumococcal vaccines include: pain, redness and swelling at injection site, occasionally an injection-site lump (may last many weeks – no treatment needed), mild fever. […] Talk to your vaccination provider about possible side effects of pneumococcal vaccines, or if you or your child have symptoms after having a pneumococcal vaccine that worry you.
  • #36 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    The pneumococcal vaccine helps protect against serious illnesses like pneumonia and meningitis. It’s recommended for people at higher risk of these illnesses, such as babies and adults aged 65 and over. […] The pneumococcal vaccine is recommended for babies, older people, and people at higher risk of getting seriously ill from pneumococcal infections. […] Contact your GP surgery if you or your child have missed a pneumococcal vaccination. […] Most people can have the pneumococcal vaccine if they need it, including if you’re pregnant or breastfeeding. […] You only cannot have the vaccine if you’ve had a serious allergic reaction (anaphylaxis) to a previous dose of the vaccine or an ingredient in the vaccine. […] If you or your child have a high temperature or feel too unwell to do your normal activities, wait until you’re feeling better before having the vaccine.
  • #37 Pneumovax 23 (pneumococcal vaccine polyvalent) dosing, indications, interactions, adverse effects, and more
    https://reference.medscape.com/drug/pneumovax-23-pneumococcal-vaccine-polyvalent-343164
    Persons who are immunocompromised, including persons receiving immunosuppressive therapy, may have a diminished immune response to vaccine. […] Vaccine may not be effective in preventing pneumococcal meningitis in patients who have chronic cerebrospinal fluid (CSF) leakage resulting from congenital lesions, skull fractures, or neurosurgical procedures.
  • #38 Pneumovax 23 (pneumococcal vaccine polyvalent) dosing, indications, interactions, adverse effects, and more
    https://reference.medscape.com/drug/pneumovax-23-pneumococcal-vaccine-polyvalent-343164
    Persons who are immunocompromised, including persons receiving immunosuppressive therapy, may have a diminished immune response to vaccine. […] Vaccine may not be effective in preventing pneumococcal meningitis in patients who have chronic cerebrospinal fluid (CSF) leakage resulting from congenital lesions, skull fractures, or neurosurgical procedures.
  • #39 Pneumococcal vaccine | Australian Government Department of Health and Aged Care
    https://www.health.gov.au/topics/immunisation/vaccines/pneumococcal-immunisation-service
    Pneumococcal vaccines should not be given to people who have had: anaphylaxis after a previous dose of any pneumococcal vaccine, anaphylaxis after any component of a pneumococcal vaccine. […] Pneumococcal vaccines are not generally recommended for pregnant women. […] Pneumococcal vaccines only come as a single vaccine, not as a combination vaccine. Different vaccines protect against different types of pneumococcal disease. It is given as a needle, usually in the upper arm. […] Common side effects of pneumococcal vaccines include: pain, redness and swelling at injection site, occasionally an injection-site lump (may last many weeks – no treatment needed), mild fever. […] Talk to your vaccination provider about possible side effects of pneumococcal vaccines, or if you or your child have symptoms after having a pneumococcal vaccine that worry you.
  • #40 Pneumonia (Pneumococcal) Vaccine | Walgreens
    https://www.walgreens.com/topic/pharmacy/scheduler/pneumonia-vaccine_2.jsp
    Children younger than 2 years old should not get Pneumovax 23 (PPSV23). […] Anyone who has ever had a life-threatening allergic reaction to the pneumococcal vaccine or to any component of the vaccine should not get another dose. […] Pregnant women should consult with their OB/GYN before getting vaccinated. […] Mild-to-moderate side effects: Redness, swelling, pain or tenderness at the injection site. […] It’s extremely rare for these vaccines to cause serious harm or death. Contact your doctor or pharmacist if you have any unexpected or worsening reactions after receiving a vaccine.
  • #41 Pneumococcal disease – immunisation | Better Health Channel
    https://www.betterhealth.vic.gov.au/health/healthyliving/pneumococcal-disease-immunisation
    Side effects from the vaccine are uncommon and usually mild, but may include: localised pain, redness and swelling at the injection site; occasionally, an injection-site lump (nodule) that may last many weeks (treatment is not needed); low-grade temperature (fever). […] If the side effect following immunisation is unexpected, persistent or severe or if you are worried about yourself or your child’s condition after a vaccination, see your doctor or immunisation nurse as soon as possible or go directly to a hospital.
  • #42 Pneumococcal Polysaccharide Vaccine: Care Instructions | Kaiser Permanente
    https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.pneumococcal-polysaccharide-vaccine-care-instructions.zc1891
    The pneumococcal polysaccharide vaccine (PPSV23) can prevent some of the serious complications of pneumonia. This includes infection in the bloodstream (bacteremia) or throughout the body (septicemia). […] PPSV23 is given as a shot. It’s usually given in the arm. Healthy older adults get the shot once. Other people may need to have a second dose. The shot may cause pain and redness at the site. It may also cause a mild fever for a short time. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It’s also a good idea to know your test results and keep a list of the medicines you take. […] Take an over-the-counter pain medicine, such as acetaminophen (Tylenol), ibuprofen (Advil, Motrin), or naproxen (Aleve), if your arm is sore after the shot. […] Watch closely for changes in your health, and be sure to contact your doctor if you have any problems.
  • #43 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    Your GP surgery will usually contact you if you or your child are eligible for the pneumococcal vaccine. […] You can get the pneumococcal vaccine at the same time as other vaccines, such as the flu vaccine. […] Like all medicines, the pneumococcal vaccine can cause side effects, but not everyone gets them. […] The most common side effects of the pneumococcal vaccine include swelling or pain where the injection was given, a high temperature, feeling tired, and loss of appetite. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] Vaccination gives the best protection against pneumococcal infections.
  • #44 Pneumococcal disease – immunisation | Better Health Channel
    https://www.betterhealth.vic.gov.au/health/healthyliving/pneumococcal-disease-immunisation
    Pneumococcal immunisation is recommended for children, especially for babies. […] Pneumococcal immunisation is also recommended for people aged 70 years and over, Aboriginal and Torres Strait Islander people aged 50 years and over and those with a serious medical risk condition. […] Serious reactions to the pneumococcal vaccines are rare. […] Immunisation can substantially reduce the risk of infection, especially in babies. Serious side effects or allergic reactions to the pneumococcal vaccine are rare. […] Pneumococcal immunisation is required for people who have: no spleen or have a spleen with poor function; a weakened immune system includes people with immune deficiency, HIV infection, people receiving chemotherapy or radiotherapy, people who have received a transplant or people with a genetic immune deficiency; leakage of fluid from around the spine and brain (cerebrospinal fluid); cochlear implants; shunts in the brain; heart disease; lung disease (including people who smoke); diabetes; down syndrome; chronic liver disease.
  • #45 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    Your GP surgery will usually contact you if you or your child are eligible for the pneumococcal vaccine. […] You can get the pneumococcal vaccine at the same time as other vaccines, such as the flu vaccine. […] Like all medicines, the pneumococcal vaccine can cause side effects, but not everyone gets them. […] The most common side effects of the pneumococcal vaccine include swelling or pain where the injection was given, a high temperature, feeling tired, and loss of appetite. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] Vaccination gives the best protection against pneumococcal infections.
  • #46 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #47 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #48 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #49 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #50 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #51 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #52 Pneumococcal vaccine polyvalent (intramuscular route, subcutaneous route) – Mayo Clinic
    https://www.mayoclinic.org/drugs-supplements/pneumococcal-vaccine-polyvalent-intramuscular-route-subcutaneous-route/description/drg-20065538
    This vaccine may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. […] The pneumococcal polyvalent vaccine will not protect you or your child against all types of pneumococcal infections. It will also not treat an active infection.
  • #53 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #54 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #55 Pneumococcal Polysaccharide Vaccine: Care Instructions | Kaiser Permanente
    https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.pneumococcal-polysaccharide-vaccine-care-instructions.zc1891
    The pneumococcal polysaccharide vaccine (PPSV23) can prevent some of the serious complications of pneumonia. This includes infection in the bloodstream (bacteremia) or throughout the body (septicemia). […] PPSV23 is given as a shot. It’s usually given in the arm. Healthy older adults get the shot once. Other people may need to have a second dose. The shot may cause pain and redness at the site. It may also cause a mild fever for a short time. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It’s also a good idea to know your test results and keep a list of the medicines you take. […] Take an over-the-counter pain medicine, such as acetaminophen (Tylenol), ibuprofen (Advil, Motrin), or naproxen (Aleve), if your arm is sore after the shot. […] Watch closely for changes in your health, and be sure to contact your doctor if you have any problems.
  • #56 Your Child’s Vaccines: Pneumococcal Vaccines (PCV, PPSV) (for Parents) | Nemours KidsHealth
    https://kidshealth.org/en/parents/pneumococcal-vaccine.html
    These vaccines are very effective at preventing severe disease, hospitalization, and even death. […] Kids may have redness, pain, or swelling where the shot was given. […] A warm, damp cloth or a heating pad on the site of the shot may help reduce soreness, as can moving or using the arm or leg. […] Call the doctor if you aren’t sure if the vaccine should be postponed or avoided. […] There are problems after the vaccination.
  • #57 Pneumococcal Polysaccharide Vaccine: Care Instructions | Kaiser Permanente
    https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.pneumococcal-polysaccharide-vaccine-care-instructions.zc1891
    The pneumococcal polysaccharide vaccine (PPSV23) can prevent some of the serious complications of pneumonia. This includes infection in the bloodstream (bacteremia) or throughout the body (septicemia). […] PPSV23 is given as a shot. It’s usually given in the arm. Healthy older adults get the shot once. Other people may need to have a second dose. The shot may cause pain and redness at the site. It may also cause a mild fever for a short time. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It’s also a good idea to know your test results and keep a list of the medicines you take. […] Take an over-the-counter pain medicine, such as acetaminophen (Tylenol), ibuprofen (Advil, Motrin), or naproxen (Aleve), if your arm is sore after the shot. […] Watch closely for changes in your health, and be sure to contact your doctor if you have any problems.
  • #58 Pneumococcal Vaccine (Pneumovax 23): Benefits
    https://my.clevelandclinic.org/health/drugs/18520-pneumococcal-vaccine-polyvalent-solution-for-injection
    Mild fever and pain should go away in 3 days or less. Report any unusual symptoms to your doctor or health care professional. […] Side effects that you should report to your doctor or health care professional as soon as possible: allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue. […] This vaccine is given in a clinic, pharmacy, doctor’s office, or other health care setting and will not be stored at home.
  • #59 Pneumococcal Polysaccharide Vaccine: Care Instructions | Kaiser Permanente
    https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.pneumococcal-polysaccharide-vaccine-care-instructions.zc1891
    The pneumococcal polysaccharide vaccine (PPSV23) can prevent some of the serious complications of pneumonia. This includes infection in the bloodstream (bacteremia) or throughout the body (septicemia). […] PPSV23 is given as a shot. It’s usually given in the arm. Healthy older adults get the shot once. Other people may need to have a second dose. The shot may cause pain and redness at the site. It may also cause a mild fever for a short time. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor if you are having problems. It’s also a good idea to know your test results and keep a list of the medicines you take. […] Take an over-the-counter pain medicine, such as acetaminophen (Tylenol), ibuprofen (Advil, Motrin), or naproxen (Aleve), if your arm is sore after the shot. […] Watch closely for changes in your health, and be sure to contact your doctor if you have any problems.
  • #60 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #61 Pneumococcal Vaccination Guidance for Nursing Home Residents: Recommendations from AMDA’s Infection Advisory Committee
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5308482/
    Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings (PA/LTC). […] Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. […] The Society strongly supports pneumococcal vaccination consistent with ACIP and Centers for Disease Control and Prevention (CDC) recommendations. […] Based on this work, the IAC developed a series of educational and implementation tools to assist PA/LTC providers when assessing residents for pneumococcal vaccination needs. […] The Society strongly advocates that Post-Acute and Long-Term Care (PA/LTC) facilities and providers establish and maintain a pneumococcal vaccination program that provides residents with access to current Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC) recommended pneumococcal vaccinations.
  • #62 Pneumococcal Vaccination Guidance for Nursing Home Residents: Recommendations from AMDA’s Infection Advisory Committee
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5308482/
    Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings (PA/LTC). […] Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. […] The Society strongly supports pneumococcal vaccination consistent with ACIP and Centers for Disease Control and Prevention (CDC) recommendations. […] Based on this work, the IAC developed a series of educational and implementation tools to assist PA/LTC providers when assessing residents for pneumococcal vaccination needs. […] The Society strongly advocates that Post-Acute and Long-Term Care (PA/LTC) facilities and providers establish and maintain a pneumococcal vaccination program that provides residents with access to current Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC) recommended pneumococcal vaccinations.
  • #63 DAL NH 16-01: Pneumococcal Vaccine
    https://www.health.state.ny.us/professionals/nursing_home_administrator/dal_nh_16-01_pneumococcal_vaccine.htm
    For adults 19-64 years of age, the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The two vaccines must not be co-administered, and the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The Department recommends LTCFs take the following steps immediately: Revise their current immunization policies and/or adopt the attached non-patient specific standing orders to ensure that all residents are screened and offered the appropriate pneumococcal vaccine. […] Ensure that all employees are educated about the pneumococcal vaccines and the ages and medical conditions for which vaccination is recommended, at their annual employee health assessment. […] Furthermore, vaccination should not be delayed due to a lack of a written immunization record. If immunization records are not available, it is acceptable to rely on the patient’s verbal immunization history to determine whether and which pneumococcal vaccine is indicated.
  • #64 DAL NH 16-01: Pneumococcal Vaccine
    https://www.health.state.ny.us/professionals/nursing_home_administrator/dal_nh_16-01_pneumococcal_vaccine.htm
    For adults 19-64 years of age, the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The two vaccines must not be co-administered, and the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] The Department recommends LTCFs take the following steps immediately: Revise their current immunization policies and/or adopt the attached non-patient specific standing orders to ensure that all residents are screened and offered the appropriate pneumococcal vaccine. […] Ensure that all employees are educated about the pneumococcal vaccines and the ages and medical conditions for which vaccination is recommended, at their annual employee health assessment. […] Furthermore, vaccination should not be delayed due to a lack of a written immunization record. If immunization records are not available, it is acceptable to rely on the patient’s verbal immunization history to determine whether and which pneumococcal vaccine is indicated.
  • #65 Pneumococcal Vaccination Guidance for Nursing Home Residents: Recommendations from AMDA’s Infection Advisory Committee
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5308482/
    Efforts at preventing pneumococcal disease are a national health priority, particularly in older adults and especially in post-acute and long-term care settings (PA/LTC). […] Nursing facility licensure regulations require facilities to assess the pneumococcal vaccination status of each resident, provide education regarding pneumococcal vaccination, and administer the appropriate pneumococcal vaccine when indicated. […] The Society strongly supports pneumococcal vaccination consistent with ACIP and Centers for Disease Control and Prevention (CDC) recommendations. […] Based on this work, the IAC developed a series of educational and implementation tools to assist PA/LTC providers when assessing residents for pneumococcal vaccination needs. […] The Society strongly advocates that Post-Acute and Long-Term Care (PA/LTC) facilities and providers establish and maintain a pneumococcal vaccination program that provides residents with access to current Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC) recommended pneumococcal vaccinations.
  • #66 Pneumococcal Vaccination Guidance for Nursing Home Residents: Recommendations from AMDA’s Infection Advisory Committee
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5308482/
    Such a program would include a requirement to assess PA/LTC residents for their pneumococcal vaccination status and to administer and document appropriate pneumococcal vaccinations in accordance with current ACIP and CDC guidance, unless the PA/LTC resident declines or has a medical contraindication or allergy. […] The tools include: A Pneumococcal Vaccination Guidance document formatted using a frequently asked question approach. The Guidance addresses common pneumococcal vaccination questions, and presents a series of common clinical vignettes designed to help providers select appropriate vaccination strategies. […] A Resident Pneumococcal Vaccination Assessment Note which helps nursing home staff complete the required resident pneumococcal vaccination assessment through use of a template note.
  • #67 Pneumococcal Vaccine – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK507794/
    All interprofessional healthcare team members, including clinicians (MDs, DOs, NPs, PAs), nursing staff, and pharmacists, should educate patients on the benefits of the pneumococcal vaccine, answer patient questions, alleviate any concerns they may have about the vaccine, and provide information for the patient in the unlikely event that they experience an adverse reaction. […] This integrated teamwork and information sharing help drive improved patient outcomes related to pneumococcal vaccination.
  • #68 Pneumococcal Pneumonia for Healthcare Providers | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/pneumonia/pneumococcal/hcp
    Studies show that when a healthcare provider strongly recommends a vaccination to a patient, immunization rates increase. Never miss an opportunity to vaccinate. Each time a patient visits your practice (through a telemedicine visit or in-person), is an opportunity to assess, identify and educate the patient on routine, recommended vaccinations including pneumococcal pneumonia. […] Healthcare providers can implement the SHARE approach to increase patient vaccine confidence. […] Healthcare providers can build a community of vaccine acceptance within the practice setting by discussing, educating, and training all staff within the practice about pneumococcal vaccination to initiate a team approach. […] Implementation of the Plan-Do-Study-Act (PDSA) method can help evidence-based interventions create lasting change.
  • #69 Pneumococcal Vaccine – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK507794/
    All interprofessional healthcare team members, including clinicians (MDs, DOs, NPs, PAs), nursing staff, and pharmacists, should educate patients on the benefits of the pneumococcal vaccine, answer patient questions, alleviate any concerns they may have about the vaccine, and provide information for the patient in the unlikely event that they experience an adverse reaction. […] This integrated teamwork and information sharing help drive improved patient outcomes related to pneumococcal vaccination.
  • #70 Pneumococcus Vaccine | AAFP
    https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines/disease-pop-immunization/pneumococcus-vaccine.html
    Pneumococcal disease can cause severe infections of the lungs (pneumonia), bloodstream (bacteremia), and lining of the brain and spinal cord (meningitis). Vaccinations are the best way to prevent pneumococcal disease. […] Current AAFP recommendations for routine use of PCV13 in adults aged 19 years with immunocompromising conditions, functional or anatomic asplenia, cerebrospinal fluid leak, or cochlear implants remain unchanged. […] Both PCV13 and PPSV23 should be administered routinely in series to all adults aged 65 years. […] Adults aged 65 years who have not previously received pneumococcal vaccine or whose previous vaccination history is unknown should receive a dose of PCV13 first, followed by a dose of PPSV23. […] The two vaccines should not be co-administered, and the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks. […] Adults aged 65 years who have previously received 1 doses of PPSV23 also should receive a dose of PCV13 if they have not yet received it. […] The recommendations for routine PCV13 use among adults aged 65 years will be reevaluated in 2018 and revised as needed.
  • #71 Pneumococcal Vaccine | L.A. Care Health Plan
    https://www.lacare.org/members/getting-care/pharmacy-services/vaccines/pneumococcal
    Pneumococcal vaccines are very good at preventing severe cases of disease that could send you to the hospital. […] Getting the vaccine can protect you, and it is especially important if you are in a higher risk group. […] All children younger than 2 years and all adults 65 years and older should get vaccinated against pneumococcal disease. […] People between the ages of 2 to 64 with certain medical conditions (such as high blood sugar or anyone with heart, liver, kidney, and lung diseases) and people who smoke cigarettes should also be vaccinated. […] There are currently four shots that protect against pneumococcal disease: Vaxneuvance (PCV15), Prevnar 20 (PCV20), Pneumovax (PPSV23), and Prevnar 13 (PCV13). One or two doses are recommended, depending on your age and health. […] You can get your pneumococcal shots at your local pharmacy or your doctor’s office.
  • #72 Pneumococcal Vaccine | L.A. Care Health Plan
    https://www.lacare.org/members/getting-care/pharmacy-services/vaccines/pneumococcal
    Pneumococcal vaccines are very good at preventing severe cases of disease that could send you to the hospital. […] Getting the vaccine can protect you, and it is especially important if you are in a higher risk group. […] All children younger than 2 years and all adults 65 years and older should get vaccinated against pneumococcal disease. […] People between the ages of 2 to 64 with certain medical conditions (such as high blood sugar or anyone with heart, liver, kidney, and lung diseases) and people who smoke cigarettes should also be vaccinated. […] There are currently four shots that protect against pneumococcal disease: Vaxneuvance (PCV15), Prevnar 20 (PCV20), Pneumovax (PPSV23), and Prevnar 13 (PCV13). One or two doses are recommended, depending on your age and health. […] You can get your pneumococcal shots at your local pharmacy or your doctor’s office.
  • #73 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    Your GP surgery will usually contact you if you or your child are eligible for the pneumococcal vaccine. […] You can get the pneumococcal vaccine at the same time as other vaccines, such as the flu vaccine. […] Like all medicines, the pneumococcal vaccine can cause side effects, but not everyone gets them. […] The most common side effects of the pneumococcal vaccine include swelling or pain where the injection was given, a high temperature, feeling tired, and loss of appetite. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] Vaccination gives the best protection against pneumococcal infections.
  • #74 Pneumococcal vaccine – NHS
    https://www.nhs.uk/vaccinations/pneumococcal-vaccine/
    Your GP surgery will usually contact you if you or your child are eligible for the pneumococcal vaccine. […] You can get the pneumococcal vaccine at the same time as other vaccines, such as the flu vaccine. […] Like all medicines, the pneumococcal vaccine can cause side effects, but not everyone gets them. […] The most common side effects of the pneumococcal vaccine include swelling or pain where the injection was given, a high temperature, feeling tired, and loss of appetite. […] More serious side effects such as a severe allergic reaction (anaphylaxis) are very rare and usually happen within minutes. […] Vaccination gives the best protection against pneumococcal infections.
  • #75 Pneumococcal Conjugate Vaccine: MedlinePlus Drug InformationLock
    https://medlineplus.gov/druginfo/meds/a610017.html
    Redness, swelling, pain, or tenderness where the shot is given, and fever, loss of appetite, fussiness (irritability), feeling tired, headache, and chills can happen after pneumococcal conjugate vaccination. […] An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
  • #76 Pneumococcal Vaccine (Pneumovax 23): Benefits
    https://my.clevelandclinic.org/health/drugs/18520-pneumococcal-vaccine-polyvalent-solution-for-injection
    Mild fever and pain should go away in 3 days or less. Report any unusual symptoms to your doctor or health care professional. […] Side effects that you should report to your doctor or health care professional as soon as possible: allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue. […] This vaccine is given in a clinic, pharmacy, doctor’s office, or other health care setting and will not be stored at home.
  • #77 Pneumococcal Pneumonia for Healthcare Providers | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/pneumonia/pneumococcal/hcp
    Studies show that when a healthcare provider strongly recommends a vaccination to a patient, immunization rates increase. Never miss an opportunity to vaccinate. Each time a patient visits your practice (through a telemedicine visit or in-person), is an opportunity to assess, identify and educate the patient on routine, recommended vaccinations including pneumococcal pneumonia. […] Healthcare providers can implement the SHARE approach to increase patient vaccine confidence. […] Healthcare providers can build a community of vaccine acceptance within the practice setting by discussing, educating, and training all staff within the practice about pneumococcal vaccination to initiate a team approach. […] Implementation of the Plan-Do-Study-Act (PDSA) method can help evidence-based interventions create lasting change.
  • #78 Pneumococcal Vaccine – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK507794/
    All interprofessional healthcare team members, including clinicians (MDs, DOs, NPs, PAs), nursing staff, and pharmacists, should educate patients on the benefits of the pneumococcal vaccine, answer patient questions, alleviate any concerns they may have about the vaccine, and provide information for the patient in the unlikely event that they experience an adverse reaction. […] This integrated teamwork and information sharing help drive improved patient outcomes related to pneumococcal vaccination.
  • #79 Pneumococcal Vaccine – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK507794/
    All interprofessional healthcare team members, including clinicians (MDs, DOs, NPs, PAs), nursing staff, and pharmacists, should educate patients on the benefits of the pneumococcal vaccine, answer patient questions, alleviate any concerns they may have about the vaccine, and provide information for the patient in the unlikely event that they experience an adverse reaction. […] This integrated teamwork and information sharing help drive improved patient outcomes related to pneumococcal vaccination.
  • #80 American Nurse Today November 2016: Which Pneumococcal Vaccine And When? A Guide For Nurses
    https://americannursetoday.mydigitalpublication.com/articles/which-pneumococcal-vaccine-and-when-a-guide-for-nurses
    Before administering either vaccine, inform patients about the risks of pneumonia, benefits of the vaccine, and risks and contraindications for the vaccine. […] Although a serious public health concern, pneumococcal disease is preventable with the two safe, highly effective vaccines discussed in this article. Be sure you know which patients to give the vaccines to and in what order. Remember as a nurse, you play an important role in vaccinating patients and educating the public on the risks of not getting vaccinated.
  • #81 Pneumococcal Pneumonia for Healthcare Providers | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/pneumonia/pneumococcal/hcp
    Studies show that when a healthcare provider strongly recommends a vaccination to a patient, immunization rates increase. Never miss an opportunity to vaccinate. Each time a patient visits your practice (through a telemedicine visit or in-person), is an opportunity to assess, identify and educate the patient on routine, recommended vaccinations including pneumococcal pneumonia. […] Healthcare providers can implement the SHARE approach to increase patient vaccine confidence. […] Healthcare providers can build a community of vaccine acceptance within the practice setting by discussing, educating, and training all staff within the practice about pneumococcal vaccination to initiate a team approach. […] Implementation of the Plan-Do-Study-Act (PDSA) method can help evidence-based interventions create lasting change.
  • #82 Pneumococcal Pneumonia for Healthcare Providers | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/pneumonia/pneumococcal/hcp
    Studies show that when a healthcare provider strongly recommends a vaccination to a patient, immunization rates increase. Never miss an opportunity to vaccinate. Each time a patient visits your practice (through a telemedicine visit or in-person), is an opportunity to assess, identify and educate the patient on routine, recommended vaccinations including pneumococcal pneumonia. […] Healthcare providers can implement the SHARE approach to increase patient vaccine confidence. […] Healthcare providers can build a community of vaccine acceptance within the practice setting by discussing, educating, and training all staff within the practice about pneumococcal vaccination to initiate a team approach. […] Implementation of the Plan-Do-Study-Act (PDSA) method can help evidence-based interventions create lasting change.
  • #83 Your Child’s Vaccines: Pneumococcal Vaccines (PCV, PPSV) (for Parents) | Nemours KidsHealth
    https://kidshealth.org/en/parents/pneumococcal-vaccine.html
    These vaccines are very effective at preventing severe disease, hospitalization, and even death. […] Kids may have redness, pain, or swelling where the shot was given. […] A warm, damp cloth or a heating pad on the site of the shot may help reduce soreness, as can moving or using the arm or leg. […] Call the doctor if you aren’t sure if the vaccine should be postponed or avoided. […] There are problems after the vaccination.
  • #84 Pneumococcal Vaccine | L.A. Care Health Plan
    https://www.lacare.org/members/getting-care/pharmacy-services/vaccines/pneumococcal
    Pneumococcal vaccines are very good at preventing severe cases of disease that could send you to the hospital. […] Getting the vaccine can protect you, and it is especially important if you are in a higher risk group. […] All children younger than 2 years and all adults 65 years and older should get vaccinated against pneumococcal disease. […] People between the ages of 2 to 64 with certain medical conditions (such as high blood sugar or anyone with heart, liver, kidney, and lung diseases) and people who smoke cigarettes should also be vaccinated. […] There are currently four shots that protect against pneumococcal disease: Vaxneuvance (PCV15), Prevnar 20 (PCV20), Pneumovax (PPSV23), and Prevnar 13 (PCV13). One or two doses are recommended, depending on your age and health. […] You can get your pneumococcal shots at your local pharmacy or your doctor’s office.
  • #85 Pneumococcal vaccines – frequently asked questions (FAQs) | NCIRS
    https://ncirs.org.au/ncirs-fact-sheets-faqs-and-other-resources/pneumococcal-vaccines-frequently-asked-questions-faqs
    The only absolute contraindication for pneumococcal vaccines is anaphylaxis (a severe allergic reaction) after a previous dose of the relevant vaccine or its components. […] In most situations, pregnant women who are recommended to receive a pneumococcal vaccine should wait until after the pregnancy to receive the vaccine. However, inadvertent administration during pregnancy is unlikely to result in serious adverse effects. […] Among Australian children, 3 doses of 13vPCV is around 90% effective in preventing IPD caused by the serotypes included in the vaccine.
  • #86 The Pneumonia Vaccine: Here’s Why You Should Get It
    https://www.aarp.org/health/drugs-supplements/pneumonia-vaccine/
    Pneumococcal infections can lead to sepsis, which is an aggressive inflammatory response that can ultimately result in organ failure and death. […] A meta-analysis of 18 studies, with over 700,000 participants, found the 23-valent polysaccharide pneumococcal vaccine (PPV23) provided protection from some cardiovascular events specifically a heart attack in people who were vaccinated, particularly those 65 years and older. […] While more studies are needed, promising research suggests that the pneumococcal vaccine may also be associated with a reduced risk of developing Alzheimer’s disease. […] Vaccinations against pneumonia before age 75 may reduce Alzheimer’s risk later in life, depending on [genetic makeup], study author Svetlana Ukraintseva said in a news release. […] The CDC recommends pneumococcal vaccines for adults 50 and older. […] Pneumococcal pneumonia leads to approximately 150,000 hospitalizations each year in the United States, CDC statistics show.
  • #87 The Pneumonia Vaccine: Here’s Why You Should Get It
    https://www.aarp.org/health/drugs-supplements/pneumonia-vaccine/
    Pneumococcal infections can lead to sepsis, which is an aggressive inflammatory response that can ultimately result in organ failure and death. […] A meta-analysis of 18 studies, with over 700,000 participants, found the 23-valent polysaccharide pneumococcal vaccine (PPV23) provided protection from some cardiovascular events specifically a heart attack in people who were vaccinated, particularly those 65 years and older. […] While more studies are needed, promising research suggests that the pneumococcal vaccine may also be associated with a reduced risk of developing Alzheimer’s disease. […] Vaccinations against pneumonia before age 75 may reduce Alzheimer’s risk later in life, depending on [genetic makeup], study author Svetlana Ukraintseva said in a news release. […] The CDC recommends pneumococcal vaccines for adults 50 and older. […] Pneumococcal pneumonia leads to approximately 150,000 hospitalizations each year in the United States, CDC statistics show.
  • #88 The Pneumonia Vaccine: Here’s Why You Should Get It
    https://www.aarp.org/health/drugs-supplements/pneumonia-vaccine/
    Pneumococcal infections can lead to sepsis, which is an aggressive inflammatory response that can ultimately result in organ failure and death. […] A meta-analysis of 18 studies, with over 700,000 participants, found the 23-valent polysaccharide pneumococcal vaccine (PPV23) provided protection from some cardiovascular events specifically a heart attack in people who were vaccinated, particularly those 65 years and older. […] While more studies are needed, promising research suggests that the pneumococcal vaccine may also be associated with a reduced risk of developing Alzheimer’s disease. […] Vaccinations against pneumonia before age 75 may reduce Alzheimer’s risk later in life, depending on [genetic makeup], study author Svetlana Ukraintseva said in a news release. […] The CDC recommends pneumococcal vaccines for adults 50 and older. […] Pneumococcal pneumonia leads to approximately 150,000 hospitalizations each year in the United States, CDC statistics show.
  • #89 Pneumococcal conjugate vaccine – what you need to know: MedlinePlus Medical EncyclopediaLock
    https://medlineplus.gov/ency/article/007605.htm
    Pneumococcal conjugate vaccine can prevent pneumococcal disease. […] Pneumococcal conjugate vaccine helps protect against bacteria that cause pneumococcal disease. […] Your health care provider can help you determine which type of pneumococcal conjugate vaccine, and how many doses, you should receive. […] Infants and young children usually need 4 doses of pneumococcal conjugate vaccine. […] Adults 19 through 64 years old with certain medical conditions or other risk factors who have not already received a pneumococcal conjugate vaccine should receive pneumococcal conjugate vaccine. […] Adults 65 years or older who have not previously received pneumococcal conjugate vaccine should receive pneumococcal conjugate vaccine. […] Talk With Your Health Care Provider […] In some cases, your health care provider may decide to postpone pneumococcal conjugate vaccination until a future visit.
  • #90 Pneumonia vaccine | Health & wellness | UnitedHealthcare
    https://www.uhc.com/health-and-wellness/health-topics/vaccines/pneumonia-vaccine
    Like most shots, you can see your doctor about getting the pneumonia vaccine. […] Theyll be able to answer questions, look at your health history and help you decide on next steps. […] If youre a good fit for the vaccine, they can get you all set to get your pneumonia shot right there in the office.